Inés Aragoncillo
About
In The Last Decade
Inés Aragoncillo
26 papers receiving 384 citations
Peers
Comparison fields: 5 of 57
- Nephrology 281
- Emergency Medical Services 148
- Surgery 115
- Pulmonary and Respiratory Medicine 88
- Hematology 70
Countries citing papers authored by Inés Aragoncillo
This map shows the geographic impact of Inés Aragoncillo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inés Aragoncillo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inés Aragoncillo more than expected).
Fields of papers citing papers by Inés Aragoncillo
This network shows the impact of papers produced by Inés Aragoncillo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inés Aragoncillo. The network helps show where Inés Aragoncillo may publish in the future.
Co-authorship network of co-authors of Inés Aragoncillo
This figure shows the co-authorship network connecting the top 25 collaborators of Inés Aragoncillo. A scholar is included among the top collaborators of Inés Aragoncillo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inés Aragoncillo. Inés Aragoncillo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 2 | |
| 3 | 7 | |
| 4 | 0 | |
| 5 | 15 | |
| 6 | 1 | |
| 7 | 9 | |
| 8 | 1 | |
| 9 | 0 | |
| 10 | 12 | |
| 11 | 14 | |
| 12 | 11 | |
| 13 | 37 | |
| 14 | 22 | |
| 15 | 24 | |
| 16 | Dose equivalence between continuous erythropoietin receptor activator (CERA), Darbepoetin and Epoetin in patients with advanced chronic kidney disease. | 15 |
| 17 | 14 | |
| 18 | 29 | |
| 19 | 38 | |
| 20 | 34 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.